Viatris (VTRS) Retained Earnings (2019 - 2026)
Viatris (VTRS) posted Retained Earnings of $18.6 billion for Q2 2026, down 0.55% on a QoQ basis from $18.7 billion in Q1 2026, and down 2.3% year-over-year from $19.0 billion in Q2 2025.
Analysis
Viatris (VTRS) Retained Earnings (2019 - 2026) Analysis & Trends
Viatris has reported Retained Earnings for 8 years, with the latest figure at $18.6 billion in Q2 2026.
- On a quarterly basis, Retained Earnings fell 2.3% year-over-year to $18.6 billion in Q2 2026; TTM through Jun 2026 was $18.6 billion, a 2.3% decrease from a year earlier, with the FY2025 full-year figure at $18.8 billion, down 0.64% from the prior year.
- Retained Earnings was $18.6 billion for Q2 2026 at Viatris, down from $18.7 billion in the prior quarter.
- The five-year high for Retained Earnings was $19.0 billion in Q2 2025, with the low at -$3.8 billion in Q3 2022.
- Average Retained Earnings over 5 years is $10.4 billion, with a median of $18.7 billion recorded in 2022.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings slumped 140.6% in 2022, then surged 744.71% in 2025.
- Over 5 years, Retained Earnings stood at $18.6 billion in 2022, then climbed by 0.91% to $18.8 billion in 2023, then increased by 0.57% to $18.9 billion in 2024, then slipped by 0.64% to $18.8 billion in 2025, then fell by 1.28% to $18.6 billion in 2026.
- The last three Retained Earnings figures came in at $18.6 billion (Q2 2026), $18.7 billion (Q1 2026), and $18.8 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 28.26 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 18.56 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 3.76 Bn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 545.58 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | -10.83 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -2.48 Bn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 620.25 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 703.65 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | -227.25 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | -413.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.56 Bn |
| Mar 31, 2026 | 18.66 Bn |
| Dec 31, 2025 | 18.80 Bn |
| Sep 30, 2025 | 18.89 Bn |
| Jun 30, 2025 | 19.00 Bn |
| Mar 31, 2025 | 18.96 Bn |
| Dec 31, 2024 | 18.92 Bn |
| Sep 30, 2024 | 18.89 Bn |
| Jun 30, 2024 | -2.98 Bn |
| Mar 31, 2024 | -2.94 Bn |
| Dec 31, 2023 | 18.81 Bn |
| Sep 30, 2023 | 18.76 Bn |
| Jun 30, 2023 | -3.01 Bn |
| Mar 31, 2023 | -2.76 Bn |
| Dec 31, 2022 | 18.65 Bn |
| Sep 30, 2022 | -3.76 Bn |
| Jun 30, 2022 | -2.90 Bn |
| Mar 31, 2022 | -2.06 Bn |
| Dec 31, 2021 | 18.54 Bn |
| Sep 30, 2021 | 18.51 Bn |